MedTrace Logo

Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A

NCT01568086 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2013-11-06

No results posted yet for this study

Summary

This is a phase Ib follow-up study to evaluate long-term safety and tolerability of immunization with AFFITOPE AD03 applied during AFFiRiS 005A.

Conditions

Sponsors & Collaborators

  • Affiris AG

    lead INDUSTRY

Principal Investigators

  • Siegfried Kasper, Prof.Dr. · Medical University of Vienna ,Department for Psychiatry and Psychotherapy

  • Dieter Volc, Prim. Dr. · Studienzentrum der PROSENEX,AmbulatoriumbetriebsgesmbH an derConfraternität-Privatklinik Josefstadt

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-06-30
Completion
2013-10-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01568086 on ClinicalTrials.gov